Skip to content
drillr
.ai
Product
▼
Datasets
▼
Docs
(opens in a new tab)
Pricing
Research
Benchmark
Sign in
Sign up
K
KALV
KalVista Pharmaceuticals, Inc.
NASDAQ
Healthcare
Biotechnology
US
NASDAQ · Healthcare · Biotechnology · US
$27.00
+0.00%
+ Watch
Ask drillr
Overview
Financials
Valuation
Profitability
Growth
Capital
Momentum
Earnings
Ownership
News
Analysis
Jun 11, 2026, 12:41 UTC
Chiesi Group completed its acquisition of KalVista Pharmaceuticals.
Source:
businesswire.com
businesswire.com
